Reaction
Paraneoplastic Neurological Syndrome reporting signals
As of the last recalculation, Paraneoplastic Neurological Syndrome appears in 124 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is ATEZOLIZUMAB (PRR 210.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Atezolizumab | 35 | 210.4 | 210.6 |
| Durvalumab | 10 | 89.7 | 89.7 |